Breakdown of oral hypoglycemic drug sales in hospitals in China 2018-2030, by agent

Of the overall oral antidiabetic drug sales in the key hospitals in China in 2018, slightly over half was contributed by acarbose and metformin. Beijing added a bunch of DDP-4 inhibitors like sitagliptin for reimbursement under government-backed insurance plans in 2017. With a drastic market growth in 2018, DDP-4 inhibitors were projected to take over acarbose as the leading revenue contributor in oral hypoglycemic medications in Chinese hospitals in 2030.

Sales distribution of oral hypoglycemic drugs in hospitals in China in 2018 and a forecast for 2030, by agent

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

October 2019



Survey time period


Special properties

based on the sales figures of oral hypoglycemic drugs from sampling hospitals

Supplementary notes


Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Denmark "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.